Skip to main content

Table 3 Methylation frequencies of selected genes in ductal carcinoma in situ and invasive breast tumors

From: Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer

  Ductal carcinoma in situ Stage I tumors Stage II tumors Stage III tumors
TLX1 4/6 (67%) 13/16 (81%) 6/8 (75%)  
CGI 7:48 3/6 (50%) 14/15 (93%) 7/9 (78%) 8/8 (100%)
HOXB13 3/6 (50%) 13/15 (87%) 8/9 (89%) 8/8 (100%)
HNF1B 3/6 (50%) 11/15 (73%) 5/9 (56%) 5/8 (63%)
GFI1 5/6 (83%) 9/12 (75%) 7/8 (88%)  
NR2E1 3/6 (50%) 8/15 (53%)